Use of diphosphonates in hypercalcaemia due to malignancy.

Suppr

超能文献

作者信息

Kanis J A, McCloskey E V, Paterson A H

出版信息

Lancet. 1990 Jan 20;335(8682):170-1.

PMID:1967461

Abstract

摘要

相似文献

Use of diphosphonates in hypercalcaemia due to malignancy.

Lancet. 1990 Jan 20;335(8682):170-1.

Use of bisphosphonates in hypercalcaemia due to malignancy.

Lancet. 1990 Mar 24;335(8691):737. doi: 10.1016/0140-6736(90)90859-4.

Immobilisation hypercalcaemia in adults and treatment with clodronate.成人制动后高钙血症及氯膦酸盐治疗

Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1111-2. doi: 10.1136/bmj.289.6452.1111.

Treatment with clodronate in patients with hypercalcemia secondary to malignancy.用氯膦酸盐治疗继发于恶性肿瘤的高钙血症患者。

Ups J Med Sci. 1987;92(3):259-63. doi: 10.3109/03009738709178696.

Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.

Lancet. 1984 Nov 3;2(8410):1043. doi: 10.1016/s0140-6736(84)91143-7.

[Diphosphonates in the treatment of hypercalcemia].[双膦酸盐在高钙血症治疗中的应用]

Rev Med Interne. 1984 Nov;5(4):363-6. doi: 10.1016/s0248-8663(84)80015-6.

Comparative effects of calcitonin and clodronate in hypercalcaemia.降钙素与氯膦酸盐对高钙血症的比较疗效

Bone. 1987;8 Suppl 1:S79-83.

Treatment of malignant hypercalcaemia with clodronate.用氯膦酸盐治疗恶性高钙血症。

Br J Cancer. 1985 May;51(5):665-9. doi: 10.1038/bjc.1985.100.

Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.双膦酸盐治疗骨转移和恶性肿瘤高钙血症。

Oncology (Williston Park). 1991 Aug;5(8):55-60; discussion 60-2, 65.

[Monotherapy with clodronate for tumor-induced hypercalcemia].[氯膦酸盐单药治疗肿瘤诱导的高钙血症]

Dtsch Med Wochenschr. 1990 Jan 12;115(2):48-52. doi: 10.1055/s-2008-1064969.

引用本文的文献

A tolerability and pharmacokinetic study of a new injectable formulation of disodium clodronate in healthy female volunteers.氯膦酸二钠新注射剂在健康女性志愿者中的耐受性和药代动力学研究。

Eur J Drug Metab Pharmacokinet. 2004 Apr-Jun;29(2):145-52. doi: 10.1007/BF03190589.

Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?氯膦酸盐治疗肿瘤引起的高钙血症时存在剂量反应关系吗？

Br J Cancer. 2002 Apr 22;86(8):1235-7. doi: 10.1038/sj.bjc.6600249.

Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.帕米膦酸盐。关于其在溶骨性骨转移、肿瘤引起的高钙血症及骨佩吉特病治疗中应用的综述。

Drugs Aging. 1998 Feb;12(2):149-68. doi: 10.2165/00002512-199812020-00007.

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.单次静脉输注氯膦酸盐有效治疗恶性高钙血症。

Br J Cancer. 1993 Mar;67(3):560-3. doi: 10.1038/bjc.1993.102.

Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.帕米膦酸盐对常规治疗无效的骨Paget病有效。

Calcif Tissue Int. 1993 Oct;53(4):237-41. doi: 10.1007/BF01320908.

Rationale for the use of alendronate in osteoporosis.阿仑膦酸盐用于治疗骨质疏松症的基本原理。

Osteoporos Int. 1995 Jan;5(1):1-13. doi: 10.1007/BF01623652.

Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.氯膦酸盐。其药理学特性及对溶骨性骨病治疗效果的综述。

Drugs. 1994 Jun;47(6):945-82. doi: 10.2165/00003495-199447060-00007.

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.用于治疗代谢性骨病的药物。临床药理学与治疗用途。

Drugs. 1993 Oct;46(4):594-617. doi: 10.2165/00003495-199346040-00003.

[Pamidronate in the treatment of tumor-associated hypercalcemia].

Klin Wochenschr. 1991 Oct 2;69(15):690-5. doi: 10.1007/BF01649438.

Medical management of hypercalcaemia.高钙血症的医学管理。

Br J Clin Pharmacol. 1992 Jul;34(1):11-20. doi: 10.1111/j.1365-2125.1992.tb04101.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验